| |
| |
|
| Insider
Information: |
Hayden Michael R |
| Relationship: |
Director |
| City: |
Burnaby |
| State: |
A1 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
322,329 |
|
|
Indirect Shares
|
1,711,659 |
|
|
| Direct
Value |
$2,280,073 |
|
|
|
Indirect Value
|
$575,479 |
|
|
| Total
Shares |
2,033,988 |
|
|
| Total
Value |
$2,855,552 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
4
|
0
|
|
Stock
price went up :
|
3
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
3.0
|
0.0
|
| Percentage
Gain/Loss : |
 183.4%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Xenon Pharmaceuticals Inc. |
XENE |
Director |
2021-05-18 |
116,206 |
2021-05-18 |
206,479 |
Premium* |
|
|
Ionis Pharmaceuticals Inc |
IONS |
Director |
2023-07-17 |
30,219 |
2023-07-17 |
2,000 |
Premium* |
|
|
89bio, Inc. |
ETNB |
|
2023-03-28 |
80,904 |
2023-03-28 |
61,538 |
Premium* |
|
|
Abcellera Biologics Inc. |
ABCL |
Director |
|
0 |
2023-09-22 |
1,441,642 |
Premium* |
|
|
Aurinia Pharmaceuticals Inc |
AUPH |
Director |
2021-01-29 |
95,000 |
2021-01-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
39 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2017-08-14 |
4 |
B |
$2.75 |
$41,247 |
D/D |
15,000 |
161,187 |
2.39 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2019-03-19 |
4 |
OE |
$3.38 |
$69,547 |
I/I |
20,576 |
50,924 |
0 |
- |
|
| ABCL |
Abcellera Biologics Inc. |
Director |
– • – |
2020-11-06 |
4 |
OE |
$0.33 |
$89,100 |
I/I |
270,000 |
985,750 |
0 |
- |
|
| ABCL |
Abcellera Biologics Inc. |
Director |
– • – |
2023-09-22 |
4 |
B |
$4.91 |
$98,200 |
I/I |
20,000 |
1,323,397 |
2.1 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2021-02-18 |
4 |
OE |
$2.68 |
$120,472 |
I/I |
41,152 |
92,076 |
0 |
- |
|
| ETNB |
89bio, Inc. |
Director |
– • – |
2021-02-23 |
4 |
OE |
$1.93 |
$172,236 |
D/D |
80,904 |
80,904 |
0 |
- |
|
| ABCL |
Abcellera Biologics Inc. |
Director |
– • – |
2023-08-08 |
4 |
B |
$5.90 |
$177,000 |
I/I |
30,000 |
1,303,397 |
2.1 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2017-03-14 |
4 |
OE |
$3.67 |
$182,200 |
D/D |
48,868 |
146,187 |
0 |
- |
|
| ETNB |
89bio, Inc. |
Director |
– • – |
2019-11-11 |
4 |
B |
$16.00 |
$300,000 |
I/I |
18,750 |
18,750 |
2.1 |
- |
|
| AUPH |
Aurinia Pharmaceuticals I... |
Director |
– • – |
2021-01-29 |
4 |
OE |
$5.44 |
$550,100 |
D/D |
95,000 |
95,000 |
0 |
- |
|
| ETNB |
89bio, Inc. |
|
– • – |
2023-03-28 |
4 |
B |
$16.15 |
$993,839 |
I/I |
61,538 |
61,538 |
0.01 |
% |
|
| ABCL |
Abcellera Biologics Inc. |
Director |
– • – |
2020-12-15 |
4 |
B |
$20.00 |
$1,473,300 |
I/I |
73,665 |
118,245 |
2.1 |
- |
|
| ABCL |
Abcellera Biologics Inc. |
Director |
– • – |
2021-06-22 |
4 |
S |
$25.50 |
$2,550,000 |
I/I |
(100,000) |
1,003,397 |
0 |
- |
|
| ABCL |
Abcellera Biologics Inc. |
Director |
– • – |
2021-09-13 |
4 |
OE |
$17.73 |
$4,787,100 |
I/I |
270,000 |
1,273,397 |
0 |
- |
|
39 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
